Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Merck & Co. and Costa Rican institute renew biological diversity agreement

Feb. 11, 1997

Genentech funds basic research related to human birth defects

Feb. 10, 1997

Vyrex gene discovery platform receives patent coverage

Feb. 10, 1997

Zynaxis sells drug delivery technology

Feb. 7, 1997

Abgenix reports significant advance in human antibody technology

Feb. 6, 1997

LifeTECH and Pall announce collaboration

Feb. 6, 1997

ICOS/Glaxo Wellcome collaboration modified

Feb. 4, 1997

Cytogen/Elan oral drug delivery collaboration advances

Feb. 4, 1997

Zeneca/Pharmacopeia collaboration signed

Jan. 31, 1997

Terrapin and Sosei commence drug discovery collaboration

Jan. 30, 1997

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026